World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
7508
World Ranking
4886
National Ranking
2186

Allan D. Hess publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Allan D. Hess sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 183 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Allan D. Hess D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Allan D. Hess sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 42 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Allan D. Hess is affiliated with Johns Hopkins University in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with significant contributions also in Medicine.

They have published work across several closely related subfields, including Molecular Biology, Immunology, Oncology, Biotechnology, and Immunology and Allergy. Their focus encompasses several main topics such as Pancreatic and Hepatic Oncology Research, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, Glycosylation and Glycoproteins Research, Immune cells in cancer, Cancer Research and Treatments, and Ubiquitin and proteasome pathways.

The scientist's recent publications include:

  • C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences, 2025, Pharmaceutics
  • Abstract 2570: Deciphering local immunosuppression in pancreatic cancer: targeting CAF-myeloid cell crosstalk to enhance immune response, 2025, Cancer Research
  • Abstract B098: RAS(ON) multi-selective inhibition remodels cancer-associated fibroblast subtypes and extracellular matrix in pancreatic cancer, 2025, Cancer Research
  • Abstract B097: pan-RAS-GTP inhibition relieves angiosuppression in PDAC by repressing Hedgehog paracrine signaling, 2025, Cancer Research

Allan D. Hess frequently collaborates with the following researchers:

  • Marie C. Hasselluhn
  • Tanner C. Dalton
  • Stephen A. Sastra
  • Carmine F. Palermo
  • Andrea Califano

Their work is consistently published in journals such as Cancer Research and Pharmaceutics, with three publications in the former and one in the latter. Their research contributions are primarily concentrated on molecular mechanisms underlying cancer development and immunological responses within oncological contexts.

Best Publications

  • Thalidomide for the treatment of chronic graft-versus-host disease.

    G B Vogelsang;E R Farmer;A D Hess;V Altamonte

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • Association of Foxp3 regulatory gene expression with graft-versus-host disease

    Yuji Miura;Christopher J. Thoburn;Emilie C. Bright;Michele L. Phelps

  • Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

    Christopher G. Kanakry;Sudipto Ganguly;Marianna Zahurak;Javier Bolaños-Meade

  • Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.

    Paul M. Colombani;Adelaide Robb;Allan D. Hess

  • Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.

    Allan D. Hess;Louis Horwitz;William E. Beschorner;George W. Santos

  • INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

    Richard J. Jones;Allan D. Hess;Risa B. Mann;Steven Piantadosi

  • Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

    Unknown

  • Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.

    A D Hess;P J Tutschka;G W Santos

  • Human immunodeficiency virus induces phosphorylation of its cell surface receptor.

    Alan P. Fields;Daniel P. Bednarik;Allan Hess;W. Stratford May

  • Successful Treatment of Murine Melanoma with Bryostatin 1

    Lynn M. Schuchter;Ahmed H. Esa;W. Stratford May;Mary K. Laulis

  • Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide

    Allan D. Hess;Emilie C. Bright;Christopher Thoburn;Georgia B. Vogelsang

  • Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.

    A D Hess;P J Tutschka;Z Pu;G W Santos

  • An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.

    Georgia B. Vogelsang;Allan D. Hess;Aron W. Berkman;Peter J. Tutschka

  • Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model.

    Georgia B. Vogelsang;Allan D. Hess;Gary Gordon;George W. Santos

  • Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.

    M J Kennedy;G B Vogelsang;R J Jones;E R Farmer

  • Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.

    A D Hess;P J Tutschka;G W Santos

  • 4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graft

    Martin Körbling;Allan D. Hess;Peter J. Tutschka;Herbert Kaizer

  • CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of the Bcl-2 Family Members Bcl-XL, Noxa, and Bak

    Kimberly N. Kremer;Kevin L. Peterson;Paula A. Schneider;X. Wei Meng

  • Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.

    Robert B. Geller;Ahmed H. Esa;William E. Beschorner;Carmellita G. Frondoza

  • MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

    K L B Knorr;P A Schneider;X W Meng;H Dai

  • Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease

    Allan D. Hess;Christopher J. Thoburn

  • Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.

    Allan D. Hess;Anne C. Fischer

  • Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras

    Peter J. Tutschka;Allan D. Hess;William E. Beschorner;George W. Santos

Frequent Co-Authors

George W. Santos
George W. Santos Johns Hopkins University
Georgia Boyce Vogelsang
Georgia Boyce Vogelsang Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Judith E. Karp
Judith E. Karp Johns Hopkins University
Richard J. Jones
Richard J. Jones Johns Hopkins University
Hyam I. Levitsky
Hyam I. Levitsky Johns Hopkins University
Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
John E. Wagner
John E. Wagner University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare-related careers, many of which benefit from additional nursing qualifications. For non-nurses seeking to enter the nursing field quickly, there are options like 12-month accelerated nursing programs online for non nurses. These programs are designed to build foundational nursing skills efficiently while allowing students to continue advancing in health sciences such as immunology.

Another popular pathway is enrolling in accelerated bsn programs for non nurses, which provide a streamlined route to becoming a registered nurse with a Bachelor of Science in Nursing. These programs complement immunology expertise, especially for those interested in clinical research or patient care involving immunological diseases.

For individuals looking for entry points into nursing with less rigorous admission criteria, easy lpn programs to get into offer a practical approach to becoming licensed practical nurses. This can serve as a valuable foundation for careers in healthcare that intersect with immunology, such as infection control or immunization clinics.

Finally, for those aiming at advanced practice roles, exploring easy nurse practitioner programs to get into can be a strategic move. Nurse practitioners with a background in immunology are well-positioned to specialize in immunology-related healthcare fields, including allergy and immunology clinics, leading to rewarding career opportunities.

Best Scientists Citing Allan D. Hess

Trending Scientists

Recently Published Articles